Sofinnova Capital VIII - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-04-30
4:06 pm
Sale
2025-03-3113GQUINCE THERAPEUTICS, INC
QNCX
Sofinnova Capital VIII5,989
2.700%
-6,000decrease
(-50.05%)
Filing
History
2025-02-14
4:29 pm
Purchase
2024-12-3113GQUINCE THERAPEUTICS, INC
QNCX
Sofinnova Capital VIII11,989
5.400%
1,211increase
(+11.24%)
Filing
History
2024-08-06
8:04 pm
Sale
2024-05-0113GQUINCE THERAPEUTICS, INC
QNCX
Sofinnova Capital VIII10,778
4.990%
-113decrease
(-1.04%)
Filing
History
2024-02-12
09:00 am
Purchase
2023-12-3113GQUINCE THERAPEUTICS, INC
QNCX
Sofinnova Capital VIII10,891
5.100%
10,891increase
(New Position)
Filing
History